[KH explains] Why Korea has been so quick to adopt ‘global minimum tax’
Health services disrupted as mass walkout by trainee doctors approaches deadline
Teachers and native English instructors now required to undergo drug testing
[Today’s K-pop] Karina of aespa is dating actor Lee Jae-wook: report
South Korea’s fertility rate drops to new low
Russia sending North Korea food in return for arms: Seoul defense chief
[Herald Interview] Rival heir to Kim Ju-ae unlikely to appear: unification minister
[Chung Chan-seung] The collapse of trust: South Korea's true health care crisis
Yoon says 2,000 increase in med school quota non-negotiable
Why Cha Eun-woo’s name keeps popping up in politics
Yuyu Pharma to attend 'CPHI Worldwide 2023'By PRNEWSWIRE
Published : Oct. 18, 2023 - 20:21
SEOUL, South Korea, Oct. 18, 2023 /PRNewswire/ -- Yuyu Pharma will be attending CPHI Worldwide in Barcelona, Spain from October 24th to October 26th.
The Yuyu Business Development team will be able to meet great partners at booth #7G30 in the Korean Trade Association pavilion to introduce Yuyu's export products such as its modified new drug Maxmarvil EC Tablet, Yuhylyx soft capsules, Yuvaro, and Senuvela Tab, among others.
In particular, Yuyu will focus on promoting projects currently under development, such as a reduced sized Dutasteride and Dutasteride-Tamsulosin combination drug. These projects are being developed with the goal of entering the U.S. and European Benign Prostate Hyperplasia
Danny Kang, Export Manager at Yuyu said "As always, we look forward to having active discussions with partners at our CPHI booth. And hope to meet new potential partners as well."
About Yuyu Pharma
With over 80 years in the healthcare industry, Yuyu Pharma (KRX: 000220) is a rapidly scaling global pharmaceutical company founded in Seoul, South Korea. Yuyu is committed to developing innovative therapeutics in the areas of neurology, dermatology, urology, and ophthalmology. Yuyu's Mission is to improve the quality of life and enhance well-being for all individuals by developing innovative healthcare products and services.
Interior minister renews calls for trainee doctors to return to work
Rival heir to Kim Ju-ae unlikely to appear: unification minister
Main opposition wrestles with exodus over nomination spat